Stock listing
2228 Stock Price, News, Filings & Events — Xtalpi Holdings Limited
Selected listing: 2228 · HKEX · HKD · HK
This page tracks Xtalpi Holdings Limited's 2228:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2228:HKEX. 2228:HKEX is the stock-level entry point for investors researching Xtalpi Holdings Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Xtalpi Holdings Limited, traded under the ticker 2228 on the Hong Kong Stock Exchange, has a market capitalization of approximately HKD 3.86 billion. The company focuses on advanced technology solutions in the pharmaceutical and biotechnology sectors. Xtalpi aims to enhance drug discovery and development processes through its innovative platform.
- Ticker
- 2228:HKEX
- Asset type
- Stock
- Market cap
- $3.78B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
Xtalpi Holdings Limited 2228:HKEX stock context
This page tracks Xtalpi Holdings Limited's 2228:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2228:HKEX. 2228:HKEX is the stock-level entry point for investors researching Xtalpi Holdings Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Xtalpi Holdings Limited, traded under the ticker 2228 on the Hong Kong Stock Exchange, has a market capitalization of approximately HKD 3.86 billion. The company focuses on advanced technology solutions in the pharmaceutical and biotechnology sectors. Xtalpi aims to enhance drug discovery and development processes through its innovative platform.
Latest news from Xtalpi Holdings Limited
XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
September 22, 2026
XtalPi Holdings Limited to Announce 2026 Interim Results on August 19, 2026
August 11, 2026
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
June 10, 2026
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
May 29, 2026
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
May 3, 2026
Research Xtalpi Holdings Limited
Xtalpi Holdings Limited investor report
Review AI stock analysis and investor report context for 2228:HKEX.
Xtalpi Holdings Limited company profile
View the public company page for Xtalpi Holdings Limited on 6ix.
Xtalpi Holdings Limited news
Read company news and market updates connected to Xtalpi Holdings Limited.
Xtalpi Holdings Limited investor events
Find investor webinars, events, and replay context for Xtalpi Holdings Limited.
Alternate listings
QNTPF:OTC
US · USD
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is 2228:HKEX.
A40DQD:LSX
DE · EUR
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is 2228:HKEX.
V0I:TRADEGATE
DE · EUR
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is 2228:HKEX.
A40DQD:LS
DE · EUR
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is 2228:HKEX.
V0I:FWB
DE · EUR
Alternate listing for Xtalpi Holdings Limited; the primary context on this page is 2228:HKEX.